If the frequency of seizures by police of hallucinogens reflects the frequency with which various hallucinogens are ingested in Australasia, most toxic states resulting from hallucinogen abuse are due to Bromo-DMA and not to LSD as is commonly reported by the subjects. Two cases of intoxication with the new hallucinogen, Bromo-DMA, are reported. Both recovered within 24 hours following treatment with haloperidol.
Get full access to this article
View all access options for this article.
References
1.
BohnG. (1981) Illegally manufactured 2,5-Dimethoxy-4-bromoamphetamine in connection with a fatal intoxication. Toxichemistry, 14, 140–141.
2.
DelliouD. (1980) Bromo-DMA: new hallucinogenic drug. Medical Journal of Australia, 1, 83.
3.
DelliouD. (1981) A Forensic Chemist's View of Some Current Hallucinogens. Presented at the Australian Seventh International Symposium on Forensic Sciences. Sydney, March 7–14.
4.
GilmanA. G.GoodmanL. S.GilmanA. (1980) The Pharmacological Basis of Therapeutics (6th Edit). MacMillan, New York.
5.
HealyP. (1978) Patterns of Drug Use in Australia 1970–1977. N.S.W. Health Commission, June, pp. 31 and 34.
6.
LishmanW. A. (1978) Organic Psychiatry — the Psychological Consequences of Cerebral Disorder. Blackwell, Oxford.
7.
MartinW. R.VaupelD. B.SloanJ. W.BellJ. A.NozakiM.BrightL. D. (1980) The mode of action of LSD-like hallucinogens and their identification. In The Psychopharmacology of Hallucinogens. (Eds ShillmanR. C.WillettR. E.) Pergamon, New York.
8.
ShulginA. T.SargentT.NaranjoC. (1971) 4-Bromo-2,5-dimethoxyphenylisopropylamine, a new centrally active amphetamine analog. Pharmacology, 5, 103–107.
9.
ShulginA. T. (1981) Profiles of psychedelic drugs — DOB. Journal of Psychoactive Drugs, 13, 99.
10.
SpreenO.BentonA. L. (1965) Comparative studies of some psychological tests for cerebral damage. Journal of Nervous and Mental Disease, 140, 323–333.
11.
SnyderS. H.FaillaceL.HollisterL. (1967) 2,5-dimethoxy-4-methyl-amphetamine (STP): a new hallucinogenic drug. Science, 158, 669–670.
12.
RusterholtzD. B.SprattJ. R.LongJ. P.KellyT. F. (1978) Serotonergic and dopaminergic involvement in the mechanism of action of R-(-)-2,5-dimethoxy-4-bromoamphetamine (DOB) in cats. Life Sciences, 23, 1499–1506.
13.
WinekC. C.CollomW. C.BrickerJ. A. (1981) A death due to 4-Bromo-2,5-dimethoxyamphetamine. Clinical Toxicology, 18, 267–271.
